SGLT2 inhibitors and dulaglutide are associated with comparable risk for dementia; however, it is uncertain whether these findings generalize to newer GLP-1 RAs.

For people having surgery unrelated to their hearts, new guidelines detail how to manage heart and stroke risks before, ...

Noninvasive, low‐level tragus stimulation modestly reduced blood pressure (BP) in relatively healthy people with grade 1 ...

A team at the Hübner and Diecke Labs at the Max Delbrück Center has shown how human and non-human primate hearts differ ...

The American Heart Association and the American College of Cardiology joint guideline addressing cardiovascular evaluation ...

Canada: Recent post hoc analyses from the VERTIS CV trial reveal promising results for ertugliflozin, a medication used to ...

The American Heart Association and the American College of Cardiology joint guideline addressing cardiovascular evaluation ...

The American Heart Association and the American College of Cardiology joint guideline addressing cardiovascular evaluation ...

Recurrent stroke risk was lower among patients with type 2 diabetes who used SGLT2 inhibitors within 3 months of ischemic stroke.

For instance, GLP-1 agonists (such as Ozempic) and SGLT2 inhibitors may help reduce the risk of heart attack and stroke and slow the progression of kidney disease. In addition, some medications ...

The 2024 guideline for cardiovascular management of adults undergoing noncardiac surgery reflects a decade of updates and new ...

The 2024 guideline for cardiovascular management of adults undergoing noncardiac surgery reflects a decade of updates and new ...